107 related articles for article (PubMed ID: 2420019)
1. The effect of verapamil on pancreatic exocrine secretion.
Burns GP; Gersten M; Bank S; Stein TA; Zimmerman HM
Surgery; 1986 Apr; 99(4):474-80. PubMed ID: 2420019
[TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.
Kayasseh L; Gyr K; Stalder GA; Rittmann WW; Girard J
Horm Res; 1978; 9(3):176-84. PubMed ID: 640582
[TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil on pancreatic exocrine secretion induced by dopamine, secretin and pancreozymin in the dog.
Iwatsuki K; Ikeda K; Chiba S
Clin Exp Pharmacol Physiol; 1982; 9(2):165-72. PubMed ID: 7127915
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic enzyme secretion during intravenous fat infusion.
Burns GP; Stein TA
JPEN J Parenter Enteral Nutr; 1987; 11(1):60-2. PubMed ID: 2434670
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of inhibition of pancreatic secretion by the beta-adrenergic agonist, terbutaline.
Joehl RJ
Pancreas; 1986; 1(3):232-8. PubMed ID: 2437567
[TBL] [Abstract][Full Text] [Related]
6. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.
Vatn MH; Schrumpf E; Hanssen KF; Myren J
J Endocrinol Invest; 1980; 3(3):279-82. PubMed ID: 6159391
[TBL] [Abstract][Full Text] [Related]
7. Effects of substance P on pancreatic exocrine secretion stimulated by secretin, dopamine and cholecystokinin in dogs.
Iwatsuki K; Yamagishi F; Chiba S
Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):663-70. PubMed ID: 2433085
[TBL] [Abstract][Full Text] [Related]
8. Effects of verapamil on exocrine pancreatic secretion in man.
Niederau C; Hellmann A; Sonnenberg A; Erckenbrecht J
Dig Dis Sci; 1985 Jan; 30(1):72-7. PubMed ID: 2578107
[TBL] [Abstract][Full Text] [Related]
9. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
[TBL] [Abstract][Full Text] [Related]
10. Blocking effects of verapamil on pancreatic exocrine secretion induced by dopamine in the dog.
Iwatsuki K; Yamagishi F; Homma N; Haruta K; Chiba S
Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):145-52. PubMed ID: 3718076
[TBL] [Abstract][Full Text] [Related]
11. Interaction of neurotensin, cholecystokinin, and secretin in the stimulation of the exocrine pancreas in the dog.
Baća I; Feurle GE; Haas M; Mernitz T
Gastroenterology; 1983 Mar; 84(3):556-61. PubMed ID: 6295872
[TBL] [Abstract][Full Text] [Related]
12. Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans.
You CH; Chey WY
Pancreas; 1988; 3(1):99-103. PubMed ID: 3362847
[TBL] [Abstract][Full Text] [Related]
13. Effects of parathyroid hormone on pancreatic exocrine secretion.
Kuroda T; Shiohara E; Haba Y; Kaneko G; Hanazaki K; Kajikawa S; Iida F
Pancreas; 1993 Nov; 8(6):732-7. PubMed ID: 7504820
[TBL] [Abstract][Full Text] [Related]
14. Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
Konturek SJ; Thor P; Dembinski A; Krol R
Gastroenterology; 1975 Jun; 68(6):1527-35. PubMed ID: 1132634
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic secretory responses to long-term infusions of secretin and cerulein in humans.
Adler G; Drewe J; Steinmetz A; Liyanage K; Beglinger C
Pancreas; 1990 Nov; 5(6):685-92. PubMed ID: 1704124
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of secretin-pancreozymin-stimulated pancreatic secretion, gallbladder contraction and choleresis after somatostatin administration].
von Kleist D; Zschiedrich M; Stopik D; Hampel KE
Dtsch Z Verdau Stoffwechselkr; 1981; 41(5):219-24. PubMed ID: 6173190
[TBL] [Abstract][Full Text] [Related]
17. Effect of secretin and graded doses of CCK-PZ on pancreatic secretion in man.
Vaysse N; Laval J; Duffaut M; Ribet A
Am J Dig Dis; 1974 Oct; 19(10):887-94. PubMed ID: 4418528
[No Abstract] [Full Text] [Related]
18. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans.
You CH; Rominger JM; Chey WY
Gastroenterology; 1983 Jul; 85(1):40-5. PubMed ID: 6303892
[TBL] [Abstract][Full Text] [Related]
19. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
[TBL] [Abstract][Full Text] [Related]
20. Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats.
Young AA; Jodka C; Pittner R; Parkes D; Gedulin BR
Regul Pept; 2005 Aug; 130(1-2):19-26. PubMed ID: 15982756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
